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1. Introduction 
The discovery [l] that S-azidoadenosine-triphos- 
phate could be used to photoaffinity label the 
(Na’ t K’)ATPase of erythrocyte ghosts has opened 
up a whole new area of endeavor in photoaffinity 
labeling. Comparable analogs of cyclic AMP [2-4], 
NAD’ [S], FAD [5], co-enzyme A [6] and GTP [7] 
have now been synthesized and used in a variety of 
labeling studies. The 8-azido-ATP or ADP analogs 
have also been used to photoaffinity label the mito- 
chondrial F1-ATPase [8] and the ADP transport 
carrier of mitochondria 191, respectively. The photo- 
affinity labeling of glutamate dehydrogenase [lo] has 
been studied with 8-azido ADP as well. A definitive 
review of photoaffinity labeling has appeared in [ 111. 
It is essential in such studies to have available 
appropriately labeled radioactive analogs. Toward this 
end we have devised an improved method of micro- 
synthesis of both 8-N3[2-3H]ATP and 8-N3[2-jH]- 
AMP-PNP in overall radiochemical yields of 3040%. 
The synthesis of 8-N3AMP-PNP has not previously 
been reported. 
2. Materials and methods 
AMP was purchased from P. L. Biochemicals; 
Abbreviations: 8-BrAMP, 8-bromoadenosine-S’-monophosphate; 
~-N&VIP, 8-azidoadenosine-5’-triphosphate; 8-N,AMP-PNP, 
8-azidoadenyl-5’-yl-imidodiphosphate; (Et) ,NH+HCO,-, 
triethylammonium bicarbonate; (Et) ,N+N,-, tetraethylam- 
monium azide; DMF, dimethylformamide; TLC, thin-layer 
chromatography; HPLC, high pressure liquid chromatography 
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[2-3H]AMP from Amersham/Searle; tetraethylammo- 
nium hydroxide from Aldrich; periodic acid from 
Sigma; potassium azide from Eastman Organic Chem- 
icals; DEAE-Sephacel (particle size 40-l 50 pm) from 
Pharmacia Chemicals; Reacti-Therm metal heating 
block and Reacti-Vials were from Pierce Chemical 
Corporation. Absorbance scans were done on a Cary-14. 
Radioactivity was measured with a liquid scintillation 
counter (Beckman LS 230) using Scinti-Verse (Fisher 
Scientific). 
Dimethylformamide and methanol were stored 
over molecular sieves. Chloroform and acetone were 
dried with activated aluminum oxide. Pyridine was 
stored over CaH,. 
2.1. Synthesis of 8-bromo[2-3H]adenosine-5’-mono- 
phosphate 
The solution of 59 nmol [2-3H]AMP (ammonium 
salt in 50% aqueous ethanol; total vol. 1 ml, 1 mCi; 
spec. act. 17 Ci/mmol) was evaporated in a small 
titration vessel (total vol. 3 ml) with a dry nitrogen 
stream. After addition of 5 pmol AMP in 1.55 ml 
Hz0 (pH 3.80) and 0.2 M sodium acetate buffer, 
pH 3.9 (0.250 ml), the titration vessel was stopped 
and protected from light. This solution was adjusted 
to pH 3.90 using 0.1 N NaOH delivered below the 
solution surface via a glass capillary from a Radio- 
meter pH stat. Freshly-prepared saturated bromine 
water (200 ~1) was added dropwise through a small 
Teflon tube to the magnetically stirred solution. The 
rate of addition of bromine water was such that the 
pH maintained by the pH stat did not drop below 
pH 3.90. After addition of all the bromine water the 
pH stat was set to maintain pH 3.95. 
After 1.5 h at room temperature the reaction mix- 
ture was directly applied to a DEAE-Sephacel column 
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Table 1 2.2. Synthesis of 8-azidof 2-3H/adenosine-5’-nzono- 










0.38 _ 21.3 
0.43 _ 23.1 
0.48 22.5 
0.33 16.9 
_ 0.44 17.5 
_ 0.49 18.4 
a TLC analyses run on Cellulose 1: plates (Baker Chem. Co.): 
Solvent A, n-butanol: acetic acid: lI,O; 5:2:3 (v/v/v); Sol- 
vent B,isobutyricacid: H,O: cont. NH,OH; 66:33:1 (v/v/v) 
b HPLC analyses used a DuPont Model 830 equipped with a 
Whatman Partisti-10 SAX column. A 2%/min gradient of 
O-5070 0.75 M KH,PO, pH 4.0 at 600 p.s.i. was used to 
separate the monophosphates and a O&100% 0.75 M 
KH,PO, (pH 4.0) at lO%/min gradient at 600 p.s.i. to 
separate the triphosphates 
The gum-like triethylammonium salt of 8-Br [2-3H]- 
AMP (5 pmol) was stored for 12 h in a vacuum desic- 
cator over P,Os. The residue was then dissolved in 
55 ~1 dry DMF and heated to 70°C in a thermostati- 
cally controlled metal heating block. (Et),N’N,-, 25 ~1 
2 M solution, in dry DMF (70°C) was added and the 
reaction temperature maintained at 70°C for 7 h. The 
yellow reaction mixture was applied directly to a 
DEAE-Sephacel column (1 .S X 70 cm) and eluted 
using a linear gradient of O-O.4 M (Et)3NH’HC0,-, 
pH 7.5 (4”C), 1 liter total vol. The appropriate 
fractions of 8-N3[2-3H]AMP (eluted at 0.23 M 
(Et)3NH’HC03-; 80% yield) were pooled and treated 
as for 8-Br[2-3H]AMP. 
(1.5 X 70 cm) and eluted using a linear gradient 
of O-O.3 M triethylammonium bicarbonate 
[(Et),NH*HCO, -1 pH 7.5 (4”C), 2 liter total vol. 
Fractions were collected at a 1 .O ml/min flow rate, 
maintained with a peristaltic pump. Unreacted [2-3H]- 
AMP was fully separated at 0.11 M (Et),NH’HCO,- 
from the major peak of 8-Br[2-3H]AMP which eluted 
at 0.14 M (Et),NH’HCO,-. The 8-Br[2-3H]AMP gave 
the characteristic AZ6s max (E = 15 100, pH 7.0) with 
anA232 min [ 121 and was judged to be free of [2-3H]- 
AMP by TLC and HPLC (table 1). 
8-N3[2-3H]AMP was identified and characterized 
by the observed shift in the A,,,, from 265-281 nm 
(E = 13 300, pH 7.0). The photolability of the analog 
was demonstrated spectrophotometrically by the 
decay of the 281 nm peak with time on exposure to 
ultraviolet light [3]. The analog was also shown to be 
pure by TLC and HPLC (cf. table 1). 
2.3. Synthesis of 8-azido(2-3H/adenyl-5’-yl-inzidodi- 
phosphate and 8-azido(2-3H]aq’cnosine-5’-tri- 
phosphate 
8-N3[2-3H]AMP (triethylammonium salt) 5 ymol, 
On occasion a small amount of a side product 
@max = 263 nm) was eluted at the front of the 8-BrAMP 
peak. This side product affected the azide displacement 
reaction by yielding a non-photolabile compound 
with an absorbance AZ7a max. Therefore only those 
fractions having an AZ65 max were pooled which 
resulted in -85% yield of 8-Br [2-3H]AMP. These 
combined fractions were evaporated to dryness under 
reduced pressure in a 300 ml pear-shaped flask (Kontes, 
Vineland, NJ), which facilitated the transfer step. The 
residue was redissolved and evaporated several 
times with anhydrous methanol to remove excess 
(Et),NH’HCO,- and water. The final residue was dis- 
solved in 1 ml anhydrous methanol, transferred to a 
0.3 ml Reacti-Vial (Pierce) stepwise with drying by a 
stream of dry nitrogen gas. 
was applied to a Dowcx 50 WX8 column (50-100 
mesh, 0.5 X 20 cm; pyridinium form prepared by 
treating the H’ form with an excess of pyridinium 
chloride made by bubbling HCl-gas into a 50/50, v/v, 
pyridine-ether mixture). The pyridinium salt of 
8-N3[2-3H]AMP was eluted with H20, dried several 
times with anhydrous pyridine under reduced pressure 
and redissolved in 2 ml dry DMF. The conversion to 
the tri-tz-octylammonium salt was achieved by addi- 
tion of 2.2 ~1 tri-II-octylamine and repeated evapora- 
tion with dry DMF. 
The tri-n-octylammonium salt of 8-N3[2-3H]AMP 
in 2 ml dry DMF was activated [ 131 by dropwise 
addition of a freshly prepared solution of 4.1 mg 
1 ,l’carbonyldiimidazole (stored under vacuum over 
P,05) in 1 ml dry DMF under vigorous stirring. The 
reaction mixture was stirred under vacuum for 24 h 
before excess 1 ,l’carbonyldiimidazole was destroyed 
by addition of 2.0 /.LI anhydrous methanol. 
Coupling of the imidodiphosphate or pyrophos- 
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phate group to the activated nucleoside$-monophos- 
phate was done according to the following procedure: 
using an equimolar amount of tri-n-octylamine (11 ~1) 
the tetrasodium salt of pyrophosphate (or imidodi- 
phosphate) [ 141 (25 pmol) was converted into the 
corresponding tri-n-octylammonium salt as described 
for 8-N3[2-3H]AMP, dissolved in 2 ml DMF and added 
dropwise under vigorous stirring to the nucleoside-S’- 
phosphoit~lidazolide. The reaction mixture was stirred 
undervacuum for 72 h. After centrifu~ation to remove 
the precipitated imidazolium pyrophosphate or 
imidazolium iinido~phosphate, the sediment was 
washed twice with 1 ml dry DMF. The combined 
supernatants were evaporated under reduced pressure 
to a small volume (2 ml) and directly applied to a 
DEAE-Sephacel column (1.5 X 70 cm). 8-Ns[2-3H]- 
ATP(eluted at 0.37 M (Et)fiH4+HC0s-) or 8-Ns[2-3H]- 
AMP-PNP (eluted at 0.33 M; 60-70% yield) were 
fully separated from side products using a linear 
gradient of O-l.0 M (Et)aNH’HCOs-, pH 7.5 (4OC), 
2 liter total vol. The triphosphate fractions were iden- 
tified by an acid labile phosphate to adenylate ratio 
of 2: 1. Further characterization was done with TLC 
and HPLC (cf. table 1). The triethylammonium salts 
of 8-Na[2-3H]AMP-PNP or 8-Ns[2-3H]ATP were con- 
verted to the sodium salts using a Dowex SO WX8 
column (Na’ form). Specific activities centered around 
37 #Zi//._mlol nucleotide. 
2.4. Synfhesis of terraethylammonium azide 
Periodic acid (I 0 mmol, 2.28 g H104 - 2 HZO) was 
mixed with 10 ml p-dioxane. Tetraethylamn~onium 
hydroxide (10 mmol, 7.1 ml 20% solution in water) 
was added with stirring until all periodic acid crystals 
had dissolved and an apparent pH 7.0 had been 
reached. Potassium azide (10 mmol, 0.8 g) was dis- 
solved in 2 ml water, added to the tetraethylammonium 
periodate solution, and stirred for 30 min. The precip- 
itated potassium periodate was removed by iiltra- 
tion, Any remaining potassium periodate was precip- 
itated by the addition of 5 vol. chloroform and 
again removed by filtration. The filtrate was evaporated 
to dryness under reduced pressure. The resulting 
(Et)+N+N,- salt was repeatedly suspended in chloro- 
form and evaporated as before until the salt changed 
from a clear gum to a white crystalline form. The 
crystals were then dissolved in 100 ml hot chloroform 
and any insoluble material (tetraethylammonium 
bicarbonate) was removed by fntration. The chloro- 
form was evaporated as before. The (Et),N’N,- was 
then recrystallized from a minimal amount of hot 
acetone, filtered quickly because of the hygroscopic 
properties of the crystals, and stored either in a vacuum 
desiccator at 22°C or dissolved in dry DMF and 
stored sealed at --20°C. Both methods have been used 
and there was no evidence of decomposition after 
4 months. 
The average yield was 75% and a molecular weight 
of 172 g was assumed to determine concentrations. 
Infrared analysis showed the characteristic azide 
stretch at 2170 cm-‘. 
3. Results and discussion 
The described synthetic procedure leads to satis- 
factory yields as well as to high specific activities of 
8-Ns[2-3H]ATP and 8-Na[2-3H]AMP-PNP. It is even 
possible to increase the amount of radioactivity in the 
starting reaction by a factor of 100 aslong as 2.5-S I.rmol 
total AMP is used in the bromination step. If smaller 
quantities of radioactive product are desired the use 
of adenosine as a carrier as suggested [3] in the prepa- 
ration of cyclic [ 32P]AMP is recommended. 
The bromination reaction was a modification of 
the procedure in [4]. The pH of the reaction was cbn- 
trolled by a pH stat to reduce the amount of sodium 
acetate buffer required, since it adversely affects the 
chromatographic resolution of 8-BrAMP and AMP on 
a DEAE-Sephacel column. Furthermore, by adding 
the freshly prepared bromine water mixture slowly 
while maint~ning pH 3.9OG3.93, side reactions could 
be almost quantitatively eliminated. Using the pH stat 
without the addition of any buffer decreased the 
yield about 10%. 
The displacement of the 8-bromo group by (Et)&Ns- 
was done in DMF at 70°C. The solubility problem of 
the nucleotide analog and azide salts in DMF was 
solved by using the thoroughly dried triethylammo- 
nium salt of 8-BrAMP and tetraethylammonium azide. 
The main advantages of the tetraethylammonium 
azide are that: 
1. It is easily prepared in crystalline form. 
2. Stock standard solutions can be made. 
3. It is readily soluble in DMF at 70°C. 
For the coupling reaction both reactants 8-NsAMP 
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and pyrophosphate or imidodiphosphate were con- 
verted to the corresponding tri-n-octylammonium 
salts because of the higher solubility of these salts in 
DMF at room temperature. Using the method in [IS] 
the excess imidodiphosphate or pyrophosphate used 
nearly coelutes from DEAE-Sephacel with the corre- 
sponding nucleoside-5’-triphosphates, a situation nor- 
mally requiring a second chromatographic separation. 
On the other hand, in the method of [ 131 excess 
imidodiphosphate or pyrophosphate precipitates as 
the imidazolium salts as the reaction proceeds and a 
single chromatographic step will yield pure nucleoside 
triphosphate derivatives. 
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